Analysts' Top Healthcare Picks: Wave Life Sciences (WVE), Passage Bio (PASG)
TipRanksApr 1 07:21 ET
Analysts Are Bullish on Top Healthcare Stocks: Quanterix (QTRX), Passage Bio (PASG)
TipRanksMar 26 07:20 ET
Passage Bio Analyst Ratings
BenzingaMar 5 09:01 ET
Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR), OrganiGram Holdings (OGI) and Passage Bio (PASG)
TipRanksDec 20, 2023 15:11 ET
Passage Bio Earns Buy Rating Based on Robust Financial Position and Promising AAV1-based GT PBFT02 Trial
TipRanksNov 14, 2023 06:05 ET
Raymond James Maintains Outperform on Passage Bio, Lowers Price Target to $5
BenzingaNov 14, 2023 03:47 ET
Passage Bio Analyst Ratings
BenzingaNov 14, 2023 03:45 ET
Wedbush Lowers Passage Bio's Price Target to $3 From $5, Maintains Outperform Rating
MT NewswiresNov 13, 2023 10:47 ET
Chardan Capital Maintains Buy on Passage Bio, Lowers Price Target to $9
BenzingaAug 8, 2023 04:28 ET
Passage Bio Analyst Ratings
BenzingaAug 8, 2023 04:28 ET
Passage Bio (PASG) Gets a Buy From Chardan Capital
TipRanksAug 7, 2023 16:35 ET
Raymond James Trims Price Target on Passage Bio to $9 From $10, Keeps Outperform Rating
MT NewswiresMay 12, 2023 09:13 ET
Raymond James Maintains Outperform on Passage Bio, Lowers Price Target to $9
BenzingaMay 12, 2023 04:37 ET
Goldman Sachs Reaffirms Their Hold Rating on Passage Bio (PASG)
TipRanksMay 11, 2023 16:25 ET
Passage Bio (PASG) Gets a Buy From BTIG
TipRanksFeb 27, 2023 06:31 ET
Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), Guardant Health (GH) and Passage Bio (PASG)
TipRanksDec 16, 2022 06:45 ET
Chardan Capital Maintains Buy on Passage Bio, Lowers Price Target to $11
Benzinga Real-time NewsDec 15, 2022 06:17 ET
Guggenheim Maintains Buy on Passage Bio, Lowers Price Target to $11
Benzinga Real-time NewsNov 11, 2022 08:44 ET
Wedbush Trims Passage Bio's Price Target to $5 From $6, Keeps Outperform Rating
MT NewswiresNov 11, 2022 07:42 ET
Canaccord Genuity Initiates Coverage On Passage Bio With Buy Rating, Announces Price Target of $8
Benzinga Real-time NewsNov 8, 2022 05:02 ET
No Data
No Data